SCHEMBL1022530

SCHEMBL1022530

O=C(O)OC1c2ccc(OCCN3CCOCC3)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.47
ESR2 Q92731 4/20 0.47
EPHX2 P34913 3/20 0.45
KDM4E B2RXH2 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
CACNA1B Q00975 1/20 0.43
MAPK14 Q16539 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
HTR7 P34969 1/20 0.42
HTR6 P50406 1/20 0.42
LCK P06239 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021841 0.92 ESR1 (0.55) ESR1ESR2KDM4ECACNA1BHTR1A
SCHEMBL1021934 0.91 EPHX2 (0.46) ESR1ESR2EPHX2MAPK14CA12
SCHEMBL1019860 0.91 EPHX2 (0.46) ESR1ESR2EPHX2MAPK14CA12
SCHEMBL1021498 0.89 ESR1 (0.45) ESR1ESR2DRD2HTR6ALDH1A1
SCHEMBL1022529 0.89 ESR1 (0.47) ESR1ESR2EPHX2KDM4ETP53
SCHEMBL1019184 0.86 MMP1 (0.47) ESR1ESR2CA12CA1CA2
SCHEMBL3536835 0.85 MMP1 (0.47) ESR1ESR2EPHX2KDM4EMAPK14
SCHEMBL1023240 0.85 MMP1 (0.56) ESR1ESR2EPHX2MMP1MMP2
SCHEMBL1020462 0.84 ESR1 (0.40) ESR1ESR2EPHX2CACNA1BMAPK14
SCHEMBL1023175 0.84 ESR1 (0.55) ESR1ESR2KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed